Anfield Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-11
Closed -$1K 118
2021
Q3
$1K Buy
+11
New +$620 ﹤0.01% 117

Other funds holding LMAT

Anfield Capital Management's LMAT Position: Q4 2021 in Review

Anfield Capital Management sold out of LeMaitre Vascular (LMAT) in Q4 2021, closing a stake of 11 shares — an estimated $1K sold.

Anfield Capital Management first reported a position in LMAT in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q4 2021.

  • Anfield Capital Management reported no remaining LeMaitre Vascular position as of Q4 2021 after selling out during the quarter.
  • Anfield Capital Management sold 11 LeMaitre Vascular shares in Q4 2021, an estimated $1K.
  • Anfield Capital Management first reported a position in LeMaitre Vascular in Q3 2021 and held it in 1 quarter.
  • Anfield Capital Management's LeMaitre Vascular position peaked at $1K in Q3 2021.
  • 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2021.

Based on Anfield Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.